Zevra Therapeutics (ZVRA) Change in Inventory (2022 - 2026)
Zevra Therapeutics (ZVRA) posted Change in Inventory of $185000.0 for Q1 2026, down 64.76% on a QoQ basis from $525000.0 in Q4 2025, and down 9.76% year-over-year from $205000.0 in Q1 2025.
Zevra Therapeutics (ZVRA) Change in Inventory (2022 - 2026) Analysis & Trends
Zevra Therapeutics' Change in Inventory history runs 5 years deep, the most recent figure standing at $185000.0 for Q1 2026.
- Quarterly Change in Inventory fell 9.76% year-over-year to $185000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 80.21% YoY) and the FY2025 annual result came in at $1.3 million, down 85.29% from the prior year.
- Change in Inventory was $185000.0 for Q1 2026 at Zevra Therapeutics, down from $525000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $4.7 million in Q4 2024 and bottomed at -$241000.0 in Q3 2022.
- A 5-year average of $625687.5 and a median of $189500.0 in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory slumped 112.03% — and 2024, when it surged 29568.75%.
- Zevra Therapeutics' Change in Inventory stood at $133000.0 in 2022, then slumped by 112.03% to -$16000.0 in 2023, then jumped by 29568.75% to $4.7 million in 2024, then plunged by 88.87% to $525000.0 in 2025, then slumped by 64.76% to $185000.0 in 2026.
- Business Quant data shows ZVRA's Change in Inventory at $185000.0 in Q1 2026, $525000.0 in Q4 2025, and $194000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 185,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 185,000.00 |
| Mar 31, 2026 | 185,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 4.72 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Sep 30, 2024 | 583,000.00 |
| Sep 30, 2024 | 583,000.00 |
| Jun 30, 2024 | 991,000.00 |
| Jun 30, 2024 | 991,000.00 |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | -16,000.00 |
| Dec 31, 2023 | -16,000.00 |